Indication
Generalized lipodystrophy
Generalized lipodystrophy is a rare, heterogeneous group of metabolic disorders characterized by a widespread or near-total absence of adipose tissue. Read more about Generalized lipodystrophy
5 drugs 5 manufacturers
Drugs that treat it
Common Generalized lipodystrophy therapies.
MYALEPT (metreleptin)
MYALEPT (metreleptin)
MYALEPT (metreleptin)
MYALEPT (metreleptin)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonGeneralized lipodystrophy is a rare, heterogeneous group of metabolic disorders characterized by a widespread or near-total absence of adipose tissue.
It encompasses both congenital forms, typically presenting in infancy or early childhood due to pathogenic genetic variants, and acquired forms that develop later in life, often associated with autoimmune conditions or panniculitis.
Pathophysiologically, the profound deficit of functional adipocytes leads to severe hypoleptinemia and ectopic lipid accumulation throughout non-adipose tissues.
This ectopic deposition triggers pronounced metabolic derangements across the endocrine and hepatic systems, clinically manifesting as extreme insulin resistance, early-onset diabetes mellitus, refractory hypertriglyceridemia, acute pancreatitis, hepatic steatosis, and an apparent pseudo-muscular phenotype.
- nih.gov
Generalized lipodystrophy is a rare, heterogeneous group of metabolic disorders characterized by a widespread or near-total absence of adipose tissue It encompasses both congenital forms, typically presenting in infancy or early childhood due to pathogenic genetic variants, and acquired forms that develop later in life, often associated with autoimmune conditions or panniculitis This ectopic deposition triggers pronounced metabolic derangements across the endocrine and hepatic systems, clinicall...
- medlineplus.gov
Generalized lipodystrophy is a rare, heterogeneous group of metabolic disorders characterized by a widespread or near-total absence of adipose tissue Pathophysiologically, the profound deficit of functional adipocytes leads to severe hypoleptinemia and ectopic lipid accumulation throughout non-adipose tissues This ectopic deposition triggers pronounced metabolic derangements across the endocrine and hepatic systems, clinically manifesting as extreme insulin resistance, early-onset diabetes melli...
- nih.gov
It encompasses both congenital forms, typically presenting in infancy or early childhood due to pathogenic genetic variants, and acquired forms that develop later in life, often associated with autoimmune conditions or panniculitis Pathophysiologically, the profound deficit of functional adipocytes leads to severe hypoleptinemia and ectopic lipid accumulation throughout non-adipose tissues
- nih.gov
Pathophysiologically, the profound deficit of functional adipocytes leads to severe hypoleptinemia and ectopic lipid accumulation throughout non-adipose tissues
Personalize your experience
Follow Generalized lipodystrophy and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.